Imidazole

Imidazole

SCHEMBL3066176

C.c1c[nH]cn1

nearest known ligand 0.00

Full drug profile on Sugi Atlas →

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Imidazole SCHEMBL22533151 1.00
Imidazole SCHEMBL13857764 1.00 ALDH1A1 (0.93)
Imidazole SCHEMBL28818418 0.97
Imidazole SCHEMBL28478036 0.97
Imidazole SCHEMBL27787391 0.97 ALDH1A1 (0.87)
Imidazole SCHEMBL1331382 0.96
Imidazole SCHEMBL2635292 0.96
Imidazole SCHEMBL1331920 0.96
Imidazole SCHEMBL30382963 0.96
Imidazole SCHEMBL2684565 0.96 ALDH1A1 (1.00)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 101 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-118027360-A Heterogeneous telomerization catalyst, and in-situ preparation method and application thereof 中国科学院青岛生物能源与过程研究所 2024-05-14 CN claimed
CN-115028583-B Super-crosslinking N-heterocyclic carbene imidazolium salt ligand, and preparation method and application thereof 中国科学院青岛生物能源与过程研究所 2023-10-24 CN claimed
US-20210094910-A1 DRUG FOR TREATING TUMOR DISEASES AND HAVING ANTIBACTERIAL ANTIVIRUS ANTI-INFLAMMATORY EFFECTS SHI JIANYOU (CN) 2021-04-01 US claimed
EP-3669869-A1 DRUG FOR TREATING TUMOR DISEASES, AND HAVING ANTIBACTERIAL, ANTIVIRUS AND ANTI-INFLAMMATORY EFFECTS Shi, Jianyou (CN) 2020-06-24 EP claimed
CN-105597568-B Chloromethylation polyether-ether-ketone/imidazoles carbon nano tube hybridized film and preparation and application 天津大学 2018-07-20 CN claimed
CN-107427758-A Utilize the separation of ion liquid solvent 切弗朗菲利浦化学公司 2017-12-01 CN claimed
CN-103897458-B A kind of environmental protection flame retardant paint 通化耐博新材料股份有限公司 2016-07-06 CN claimed
CN-105597568-A Chloromethylated polyether-ether-ketone/imidazole carbon nano tube hybrid membrane, preparation and application UNIV TIANJIN 2016-05-25 CN claimed
US-8853417-B2 Non-halogen activating agent used as flux HUNAN ASTAR BIOTECHNOLOGY LTD. (CN) 2014-10-07 US claimed
CN-1709575-A One-step-finished alpha-olefin isomerization and cross displacement reaction catalyst JIHUA GROUP CO (CN) 2005-12-21 CN claimed
US-12478064-B2 Microcapsules and processes for their preparation YISSUM RESEARCH DEVELOPMENT COMPANY OF THE HEBREW UNIVERSITY OF JERUSALEM LTD. (IL) 2025-11-25 US disclosed
CN-118048635-A Ionic liquid assisted phthalocyanine molecule coupling g-C3N4Heterojunction and photoelectrocatalytic reduction of CO2Application of alcohol production 山东朋福新材料科技有限公司 2024-05-17 CN disclosed
CN-118027360-A Heterogeneous telomerization catalyst, and in-situ preparation method and application thereof 中国科学院青岛生物能源与过程研究所 2024-05-14 CN disclosed
US-20240099122-A1 ORGANIC ELECTROLUMINESCENT DEVICE AND APPLICATION THEREOF Beijing Summer Sprout Technology Co., Ltd. (CN) 2024-03-21 US disclosed
EP-3713666-B1 PROCESSES FOR THE PREPARATION OF MICROCAPSULES YISSUM RES DEV CO OF HEBREW UNIV JERUSALEM LTD (IL) 2024-02-28 EP disclosed
US-20050069492-A1 Imidazo [2,1-b]-1,3,4-thiadiazole suflonamides PHARMASCIENCE INC. (CA) 2005-03-31 US disclosed
EP-1463735-A1 IMIDAZO[2,1-B]-1,3,4-THIADIAZOLE SULFONAMIDES Aegera Therapeutics Inc. (CA) 2004-10-06 EP disclosed
WO-2003051890-A1 IMIDAZO [2,1-B]-1,3,4-THIADIAZOLE SUFLONAMIDES AEGERA THERAPEUTICS INC. (CA) 2003-06-26 WO disclosed
CN-1057099-C Synthetic peptides, intermediates therefor and process for producing the same MITSUBISHI TOYKO PHARMACEUTICA (JP) 2000-10-04 CN disclosed
CN-1136813-A Novel synthetic peptide, lung surfactant containing the same and remedy for respiratory distress syndrome TOKYO TANABE PHARMACEUTICAL CO (JP) 1996-11-27 CN disclosed